Literature DB >> 24629822

The association between Cytotoxic T lymphocyte associated antigen-4, Fas, tumour necrosis factor-α gene polymorphisms and autoimmune hepatitis: a meta-analysis.

Baodong Qin1, Jiangyan Li1, Yan Liang1, Zaixing Yang2, Renqian Zhong3.   

Abstract

BACKGROUND: Several previous studies have assessed the association of Cytotoxic T Lymphocyte Associated Antigen-4, Fas, and Tumour Necrosis Factor-α gene polymorphisms with autoimmune hepatitis risk, but the results were inconsistent and inconclusive. We performed a meta-analysis to better evaluate these associations.
METHODS: PubMed, EMBASE and MEDLINE were searched in all languages. Overall odd ratios with 95% confidence intervals were calculated to assess the strength of associations using a fixed-effects or random-effects models.
RESULTS: 15 relevant studies were identified. No significant association was found between CTLA-4+49A/G and AH. TNF-α-308A/G was significantly associated with autoimmune hepatitis risk. Individuals with the "A" allele had a 67% increased risk of autoimmune hepatitis (odds ratio=1.67, 95% confidence interval 1.11-2.52). The genotype "AA" was a potential predisposing factor for autoimmune hepatitis, when compared with the genotype "GG" and "AG+GG" (odds ratio=2.71, 95% confidence interval 1.12-6.57; odds ratio=2.14, 95% confidence interval 1.30-3.52). Besides, no significant association was found between the Fas-670G/A and TNF-α-238A/G polymorphisms and autoimmune hepatitis risk using any model.
CONCLUSION: The meta-analysis identified the TNF-α-308 "A" allele as a predisposing factor for autoimmune hepatitis, whereas the genotype "GG" was a protective factor. This study did not find a significant association between CTLA-4+49A/G, Fas-670G/A, TNF-α-238A/G and susceptibility to autoimmune hepatitis.
Copyright © 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmune hepatitis; CTLA-4; Fas; Polymorphisms; TNF-α

Mesh:

Substances:

Year:  2014        PMID: 24629822     DOI: 10.1016/j.dld.2014.02.003

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  6 in total

1.  Fas/FasL gene polymorphism in patients with Hashimoto's thyroiditis in Turkish population.

Authors:  M Erdogan; M Kulaksizoglu; S Ganidagli; A Berdeli
Journal:  J Endocrinol Invest       Date:  2016-08-30       Impact factor: 4.256

2.  Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.

Authors:  C R Grant; B S Holder; R Liberal; M A Heneghan; Y Ma; G Mieli-Vergani; D Vergani; M S Longhi
Journal:  Clin Exp Immunol       Date:  2017-03-27       Impact factor: 4.330

3.  rs10499194 polymorphism in the tumor necrosis factor-α inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population.

Authors:  Enbin Xu; Hailian Cao; Liming Lin; Honglong Liu
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

Review 4.  Novel Diagnostic and Therapeutic Strategies in Juvenile Autoimmune Hepatitis.

Authors:  Marco Sciveres; Silvia Nastasio; Giuseppe Maggiore
Journal:  Front Pediatr       Date:  2019-09-20       Impact factor: 3.418

5.  Association between FAS gene -670 A/G and -1377 G/A polymorphisms and the risk of autoimmune diseases: a meta-analysis.

Authors:  Hongwei Yan; Yuxiao Hong; Yunfei Cai
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

Review 6.  Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis.

Authors:  Rossella Fasano; Eleonora Malerba; Marcella Prete; Antonio Giovanni Solimando; Alessio Buonavoglia; Nicola Silvestris; Patrizia Leone; Vito Racanelli
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.